A new trading day began on Tuesday, with Prothena Corporation plc (NASDAQ: PRTA) stock price up 3.65% from the previous day of trading, before settling in for the closing price of $4.66. PRTA’s price has ranged from $4.32 to $25.42 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 178.00%. Meanwhile, its annual earnings per share averaged -62.11%. With a float of $42.32 million, this company’s outstanding shares have now reached $53.83 million.
The extent of productivity of a business whose workforce counts for 163 workers is very important to gauge. In terms of profitability, gross margin is 57.64%, operating margin of -100.49%, and the pretax margin is -84.0%.
Prothena Corporation plc (PRTA) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Prothena Corporation plc is 21.38%, while institutional ownership is 74.04%. The most recent insider transaction that took place on May 02 ’25, was worth 27,744,929. In this transaction 10% Owner of this company sold 3,317,938 shares at a rate of $8.36, taking the stock ownership to the 8,266,342 shares. Before that another transaction happened on May 06 ’25, when Company’s 10% Owner sold 1,984,053 for $7.64, making the entire transaction worth $15,164,712. This insider now owns 5,304,596 shares in total.
Prothena Corporation plc (PRTA) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -62.11% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -15.31% during the next five years compared to -3.15% drop over the previous five years of trading.
Prothena Corporation plc (NASDAQ: PRTA) Trading Performance Indicators
Here are Prothena Corporation plc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 9.00. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.88.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.08, a number that is poised to hit -1.04 in the next quarter and is forecasted to reach -3.07 in one year’s time.
Technical Analysis of Prothena Corporation plc (PRTA)
The latest stats from [Prothena Corporation plc, PRTA] show that its last 5-days average volume of 3.33 million was superior to 0.94 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 12.05%. Additionally, its Average True Range was 0.61.
During the past 100 days, Prothena Corporation plc’s (PRTA) raw stochastic average was set at 4.13%, which indicates a significant decrease from 15.09% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 158.04% in the past 14 days, which was higher than the 82.67% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.86, while its 200-day Moving Average is $14.49.
